Efficiency and cost analysis of cell saver auto transfusion system in total knee arthroplasty

Basit Öğe Kaydı
dc.contributor.authorBilgili, Mustafa Gökhan
dc.contributor.authorErçın, Ersin
dc.contributor.authorPeker, Gökhan
dc.contributor.authorKural, Cemal
dc.contributor.authorBaşaran, Serdar Hakan
dc.contributor.authorDuramaz, Altug
dc.contributor.authorAvkan, Cevdet
dc.date.accessioned2024-09-29T16:34:59Z
dc.date.available2024-09-29T16:34:59Z
dc.date.issued2014
dc.departmentKarabük Üniversitesien_US
dc.description.abstractBackground: Blood loss and replacement is still a controversial is- sue in major orthopaedic surgery. Allogenic blood transfusion may cause legal problems and concerns regarding the transmission of transfusion-related diseases. Cellsaver Systems (CSS) were devel- oped as an alternative to allogenic transfusion but CSS transfusion may cause coagulation, infection and haemodynamic instability. Aims: Our aim was to analyse the efficiency and cost analysis of a cell saver auto-transfusion system in the total knee arthroplasty pro- cedure. Study Design: Retrospective comparative study. Methods: Those patients who were operated on by unilateral, ce- mented total knee arthroplasty (TKA) were retrospectively evalu- ated. Group 1 included 37 patients who were treated using the cell saver system, and Group 2 involved 39 patients who were treated by allogenic blood transfusion. The groups were compared in terms of preoperative haemoglobin and haematocrit levels, blood loss and transfusion amount, whether allogenic transfusion was made, degree of deformity, body mass index and cost. Results: No significant results could be obtained in the statistical comparisons made in terms of the demographic properties, deformity properties, preoperative laboratory values, transfusion amount and length of hospital stay of the groups. Average blood loss was calcu- lated to be less in Group 1 (p<0.05) and cost was higher in Group 1 (p<0.05). Conclusion: Cell saver systems do not decrease the amount of allo- genic blood transfusion and costs more. Therefore, the routine usage of the auto-transfusion systems is a controversial issue. Cell saver system usage does not affect allogenic blood transfusion incidence or allogenic blood transfusion volume. It was found that preoperative haemoglobin and body mass index rates may affect allogenic blood transfusion. Therefore, it is foreseen that auto-transfusion systems could be useful in patients with low haemoglobin level and body mass index.en_US
dc.identifier.endpage153en_US
dc.identifier.issn2146-3123
dc.identifier.issue2en_US
dc.identifier.startpage149en_US
dc.identifier.trdizinid168876en_US
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/168876
dc.identifier.urihttps://hdl.handle.net/20.500.14619/12413
dc.identifier.volume31en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofBalkan Medical Journalen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCerrahien_US
dc.titleEfficiency and cost analysis of cell saver auto transfusion system in total knee arthroplastyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu